Wellington Management Group
NAVB

Wellington Management Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Wellington Management Group’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-24,676
Closed -$933K – 2275
2014
Q4 		$933K Sell
24,676
-121,578
-83% -$3.34M ﹤0.01% 1872
2014
Q3 		$3.86M Sell
146,254
-4,099
-3% -$108K ﹤0.01% 1512
2014
Q2 		$4.45M Sell
150,353
-2,284
-1% -$73.9K ﹤0.01% 1486
2014
Q1 		$5.65M Sell
152,637
-2,419
-2% -$91.7K ﹤0.01% 1414
2013
Q4 		$6.42M Buy
+155,056
New +$6.07M ﹤0.01% 1384

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group's NAVB Position: Q1 2015 in Review

Wellington Management Group sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2015, closing a stake of 24,676 shares — an estimated $933K sold.

Wellington Management Group first reported a position in NAVB in Q4 2013 and held it in 5 quarters. The position peaked at $6.42M in Q4 2013. 82 funds tracked by Wall St. Rank hold NAVB as of Q1 2015.

  • Wellington Management Group reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2015 after selling out during the quarter.
  • Wellington Management Group sold 24,676 Navidea Biopharmaceuticals Inc. shares in Q1 2015, an estimated $933K.
  • Wellington Management Group first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2013 and held it in 5 quarters.
  • Wellington Management Group's Navidea Biopharmaceuticals Inc. position peaked at $6.42M in Q4 2013.
  • 82 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2015.

Based on Wellington Management Group's 13F filing for Q1 2015, filed 15 May 2015.